The Financial Post reports in its Thursday edition that U.S. President Donald Trump said his long-promised tariffs on pharmaceutical drugs will be coming soon, the latest signal that he plans to press ahead with more sectoral tariffs despite market fallout from his global levies. A Bloomberg dispatch to the Post quotes Mr. Trump telling a fundraiser Tuesday: "We are going to be announcing very shortly a major tariff on pharmaceuticals. Once we do that, they're going to come rushing back into our country." Mr. Trump has long bemoaned a lack of domestic pharmaceutical production and has repeatedly promised tariffs to bring more capacity into the country. An index of European health-care companies dropped to a 2-1/2-year low Wednesday, with shares in Astrazeneca PLC, Novo Nordisk A/S and Roche Holding AG falling around 7 per cent before paring losses. A lack of information about the place of manufacturing of drug components makes any assessment of the impact of potential tariffs challenging, but companies with the lowest gross margins could face the biggest adverse earnings impact. Mr. Trump has signalled he will use Section 232 powers to enact the levies, though the White House has not launched the required investigation.